BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 3940095)

  • 1. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
    Cockerell CJ; Berson DS
    Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of clinical and histopathologic features in clinically atypical melanocytic nevi.
    Barnhill RL; Roush GC
    Cancer; 1991 Jun; 67(12):3157-64. PubMed ID: 2044059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.
    Ackerman AB; Mihara I
    Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389
    [No Abstract]   [Full Text] [Related]  

  • 11. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; OkoĊ„ K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursors to melanoma and their mimics: nevi of special sites.
    Elder DE
    Mod Pathol; 2006 Feb; 19 Suppl 2():S4-20. PubMed ID: 16446715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of melanocytic nevi as a major risk factor for malignant melanoma.
    Holly EA; Kelly JW; Shpall SN; Chiu SH
    J Am Acad Dermatol; 1987 Sep; 17(3):459-68. PubMed ID: 3655025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histopathology of dysplastic nevi. Continued controversy.
    Roth ME; Grant-Kels JM; Ackerman AB; Elder DE; Friedman RJ; Heilman ER; Maize JC; Sagebiel RW
    Am J Dermatopathol; 1991 Feb; 13(1):38-51. PubMed ID: 2003647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
    Ko CJ; McNiff JM; Glusac EJ
    J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL; King LE; Nanney LB
    J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.